Solar Capital Ltd. (SLRC)
| Previous close | 15.53 |
| Open | 15.44 |
| Bid | 15.34 x 100 |
| Ask | 15.45 x 200 |
| Day's range | 15.38 - 15.44 |
| 52-week range | 13.48 - 15.86 |
| Volume | |
| Avg. volume | 199,975 |
| Market cap | 839.05M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 10.99 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.64 (10.56%) |
| Ex-dividend date | 13 Mar 2024 |
| 1y target est | N/A |
- GlobeNewswire
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended March 31, 2024
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended March 31, 2024 on Wednesday, May 8, 2024 after the close of the financial markets. The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Thursday, May 9, 2024. All interested parties may participate in the conference call by dialing (800) 445-7795 approximately 5-10 minutes p
- GlobeNewswire
SLR Investment Corp. Announces Quarter and Year Ended December 31, 2023 Financial Results
Net Investment Income of $0.44 Per Share for Q4 2023; Declared Quarterly Distribution of $0.41 Per Share; Stable NAV and Strong Portfolio Credit Quality NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SLR Investment Corp. (NASDAQ: SLRC) (the “Company”, “SLRC”, “we”, or “our”) today reported net investment income of $23.9 million, or $0.44 per share, for the fourth quarter of 2023. As of December 31, 2023, net asset value (NAV) was $18.09 per share, compared to $18.06 as of September 30, 2023. In the
- GlobeNewswire
SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, today announced that it has secured $85 million in financing including $25 million in Series D-1 insider equity and a $60 million debt facility. The equity financing was led by Revelation Partners, SPR’s lead investor of the Series D equity financing, and incumbent investors, RC Capital and Mutual C
